A cascade screening approach for the identification of Bcr-Abl myristate pocket binders active against wild type and T315I mutant-Reference-Cited by-同舟云学术

A cascade screening approach for the identification of Bcr-Abl myristate pocket binders active against wild type and T315I mutant

Published:2016-08 Issue:15 Volume:26 Page:3436-3440
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Radi Marco,Schneider Ralf,Fallacara Anna Lucia,Botta Lorenzo,Crespan Emmanuele,Tintori Cristina,Maga Giovanni,Kissova Miroslava,Calgani Alessia,Richters André,Musumeci Franesca,Rauh Daniel,Schenone Silvia

Funder

National Interest Research Project

German Federal Ministry of Education and Research

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference22 articles.

1. Hypoxia-inducible factors in cancer stem cells and inflammation

2. Is cure of chronic myeloid leukemia in the third millennium a down to earth target (ed) or a castle in the air?

3. Impact of Timely Switching From Imatinib to a Second-Generation Tyrosine Kinase Inhibitor After 12-Month Complete Cytogenetic Response Failure: A Chart Review Analysis

4. The Accelerated Approval of Oncologic Drugs

5. Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico approaches for drug repurposing in oncology: a scoping review;Frontiers in Pharmacology;2024-06-11

2. Screening of break point cluster region Abelson tyrosine kinase inhibitors by capillary electrophoresis;Journal of Chromatography A;2018-02